Search

everythinglearnresearchcommunity

for

Search:↓

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

The Rotterdam Study updated its design and objectives in 2012, providing insights into various diseases in the elderly, including skin cancer, bone health, liver disease, neurological and psychiatric conditions, and respiratory issues.

The Rotterdam Study aims to understand various diseases in older adults.

Advanced human skin models improve drug development and could replace animal testing.

Certain drugs that block specific enzymes can help treat prostate diseases.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

COVID-19 may cause hair loss, often after recovery, with androgenetic alopecia being the most common type.

Menopause causes significant changes in the vaginal introitus, but less so in the labia majora, which may lead to symptoms of vaginal atrophy.

Finasteride improves heart function and repairs damage after heart attack in mice.

Finasteride improves heart function and repairs damage after heart attack in mice.

Fewer GGC sequences in the androgen receptor gene improve finasteride treatment for hair loss.

Laser therapy on human skin affects the HERC6 gene and related genes, influencing many cell processes and requiring careful safety measures.

Targeted therapy with Ustekinumab significantly improved a skin condition called ILVEN, which is caused by mutations in the CARD14 gene.

Chemotherapy and radiation therapy cause skin and hair damage by altering gene expression and signaling pathways.

Five molecular elements identified as potential future targets for hair loss therapy.

RCS-01 therapy is safe and may improve skin structure by affecting gene expression.

Methylation in specific gene region causes finasteride resistance in some BPH patients.

Identical p53 gene mutations in different cancers suggest the need for careful treatment.

Mitochondrial therapy and platelet-rich plasma therapy both stimulated hair regrowth in aging mice, with mitochondrial therapy showing similar effectiveness to plasma therapy.

Lower levels of certain genes in hair cells improve hair loss treatment outcomes.

Stem cell therapy affects 15 key genes in rats with diabetes-related erectile dysfunction.

SH-MSCs gel reduced IL-6 and increased TGF-β, suggesting it could treat alopecia.

Certain gene variations are linked to severe acne in Egyptian patients and could guide treatment choices.

Women with greater androgen sensitivity respond better to finasteride for hair loss.

Antiandrogen therapy helps treat genetic hair loss.

Radiation therapy in breast cancer patients changes gene expression related to DNA damage, fibroblast growth, and hair follicle development, which could help improve treatment for radiation-induced fibrosis.

Umbilical cord blood transplantation improved the boy's symptoms despite complications.

An American Bully with a genetic skin condition improved significantly with specific topical treatments.